Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase NA 6Phase 3 6Phase 2/3 2Phase 1 2

Status

Unknown 4Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 641OTHER 355NIH 54NETWORK 40OTHER_GOV 15UNKNOWN 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 13Breast 9Thoracic 6Head & Neck 2CNS 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Small Cell Lung Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Thymoma 1Thoracic Neoplasms 1Lung Neoplasms 1Carcinoma, Small Cell 1Carcinoma 1Brain Neoplasms 1

Interventions

aumolertinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Pemetrexed 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Thoracic × Clear all
NCT04762459 2022-02-24

APEX

ChineseAMS

Phase 3 Enrolling by invitation
606 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04500145 2021-02-01

Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer

ChineseAMS

Phase 3 Unknown
350 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00880971 2020-10-05

Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer

ChineseAMS

Phase 3 Completed
394 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Thoracic Neoplasms

NCT04535739 2020-09-02

PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study

ChineseAMS

Phase 3 Unknown
414 enrolled
CNSThoracic

Brain Neoplasms, Small Cell Lung Carcinoma

NCT02014805 2020-07-16

Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma

ChineseAMS

Phase 3 Unknown
210 enrolled
Thoracic

Thymoma

NCT02688036 2018-01-02

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC

ChineseAMS

Phase 3 Unknown
860 enrolled
Thoracic

Lung Neoplasms, Carcinoma, Small Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡